Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
about
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseRisk multipliers for severe food anaphylaxisLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsTo hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolasePhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionProteomics investigations of HDL: challenges and promiseCharacterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cellsPlatelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoproteinHydrolysis of platelet-activating factor by human serum paraoxonasePlatelet aggregation unchanged by lipoprotein-associated phospholipase A₂ inhibition: results from an in vitro study and two randomized phase I trialsGenome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study.Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy.Molecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the Structure.Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B.Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.The emerging roles of PAF acetylhydrolase.Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells.In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombinThe metabolic serine hydrolases and their functions in mammalian physiology and disease.Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase.Crystallization and preliminary X-ray crystallographic analysis of human plasma platelet activating factor acetylhydrolase.Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic childrenPartial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cellsCharacterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.Determination of phospholipase activity of PAF acetylhydrolaseLipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPSStructural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometryPAF and Haematopoiesis. I. 5-Fluoro-Uracil Induces PAF Production in Haematopoietic Organs of Rats.Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution.The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients.Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults.Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyondRadiation therapy generates platelet-activating factor agonistsPlatelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation.
P2860
Q24562119-FD353748-D77E-47A9-AF64-7CB7B366D2A5Q26774573-D7437065-3BE2-4F75-90C8-E4A8BB1D1491Q26777871-47110104-00EC-42F4-B552-91C4CA49B3AAQ26865969-FD51C154-B057-42E9-9BAA-A34E1162D476Q26997377-E64632E2-245A-4DA4-8030-292DAD315157Q27000995-CB2675A7-011F-491C-A2DF-064A47B87936Q28219806-02237B56-5CFF-4163-BF74-F98B5414A6A3Q28343585-6ACAA75E-E981-42D6-8951-02D9DD94E97DQ28347908-EFC925BB-3060-4DF7-839E-CA2A9A1C9C8CQ28539153-DC585403-ECAB-4120-AC8F-CF0330464724Q30484496-3E556DB2-0C57-420D-97D9-EE30A31F2AA6Q33575941-C4E1C290-5A1F-4886-AB7F-2DBC030CDB26Q33664201-892634F8-40B8-4188-82B3-8CA1B30DE8CFQ33666216-45F18CBC-86DA-485E-ADA9-0DB4C2C6D6D2Q33847969-9DC7E008-979D-4705-B9D7-837A40FBC2DCQ33895653-837DC737-2AB7-4D0B-8C1B-98D323247B5AQ34464823-62B4ACB6-424B-4E97-A8A9-7333328407E5Q34613089-FA99C8AD-5146-406B-B58A-E5AB760ABB25Q34847192-BC07281B-8878-4F7E-92DA-350EE45B2C4EQ34945329-659019B9-49DF-4607-A3CA-DA4419F9FA47Q35183189-B0B95A06-C7C1-4EBE-90DC-37CD68699152Q35333042-6C8D0A6E-AC77-4C1B-A6F3-6102371E677EQ35548859-79255C26-E292-430F-ACF5-EA096677AE96Q35563996-B7331345-B88A-430D-8786-641FB9C63E7DQ35594599-2BD68B72-DC32-415D-AD95-D59EE9DC27CCQ35673608-7F2E159D-2BCE-4576-B1D0-9FAFCD1EEB0FQ35766281-15E5ABE5-65B3-4BD3-B581-73037678A3D4Q35848282-936A4863-9855-467A-A0B9-54D2795930BAQ36145180-7BA97F18-F39E-44BA-BD3B-2360C3F5DFF9Q36222548-1FFD8122-EA9F-451F-943A-A224616F97ECQ36240691-9B0120CA-EF5E-44A7-B634-8DC6AF41049FQ36363607-7049BF7F-0B3D-4F98-BCE6-BEA370BFAFD6Q36462031-3E7905B6-A7BB-4239-83F7-0E1D58D9C94EQ36631605-4969BCBB-C410-4FC0-BBD2-F66961437B73Q36899258-D52E1D55-1A3F-442C-8F3C-E56FBF40C83BQ36903325-C4B0694E-FC4D-481C-B91A-53A4E7886D3DQ37001368-C8AA428B-DF9D-4054-9E21-62AC34F7DB13Q37162996-0B447E81-24EF-4F30-9B4F-8DADE9EF2392Q37190440-ED30F9D3-4B5B-4F8D-BE50-146E5898AE96Q37485044-4A779F04-F336-4AB7-8B0D-39FFF5C8A6E3
P2860
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Human plasma platelet-activati ...... of platelet-activating factor.
@ast
Human plasma platelet-activati ...... of platelet-activating factor.
@en
Human plasma platelet-activati ...... of platelet-activating factor.
@nl
type
label
Human plasma platelet-activati ...... of platelet-activating factor.
@ast
Human plasma platelet-activati ...... of platelet-activating factor.
@en
Human plasma platelet-activati ...... of platelet-activating factor.
@nl
prefLabel
Human plasma platelet-activati ...... of platelet-activating factor.
@ast
Human plasma platelet-activati ...... of platelet-activating factor.
@en
Human plasma platelet-activati ...... of platelet-activating factor.
@nl
P2093
P1476
Human plasma platelet-activati ...... of platelet-activating factor
@en
P2093
D M Stafforini
M E Carter
S M Prescott
T M McIntyre
P304
P407
P577
1987-03-01T00:00:00Z